PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Cancer 1,053,491 Disease Drug Ascorbic Acid (Vitamin C)- FDA 20 2 0.00 -0.95 0.10 0.54
Cancer 1,053,491 Disease Disease Acute Promyelocytic Leukemia 4,780 490 0.01 -0.95 0.10 0.56
Cancer 1,053,491 Disease Target A1AT 329 34 0.00 -0.95 0.10 0.55
Cancer 1,053,491 Disease Target BMP-6 386 40 0.00 -0.95 0.10 0.55
Cancer 1,053,491 Disease Target CXCL11 526 55 0.00 -0.95 0.10 0.55
Cancer 1,053,491 Disease Target 464.1 19 2 0.00 -0.95 0.11 0.54
Cancer 1,053,491 Disease Target Beta-Tubulin 4,870 513 0.01 -0.95 0.11 0.57
Cancer 1,053,491 Disease Target ERK2 3,287 347 0.01 -0.95 0.11 0.56
Cancer 1,053,491 Disease Drug Avandia (Rosiglitazone Maleate)- FDA 66 7 0.00 -0.95 0.11 0.54
Cancer 1,053,491 Disease Target B2M 677 72 0.00 -0.95 0.11 0.55
Cancer 1,053,491 Disease Disease Secondhand Smoke 1,334 142 0.00 -0.95 0.11 0.56
Cancer 1,053,491 Disease Target Sphingosine 1-Phosphate Receptor 1 150 16 0.00 -0.95 0.11 0.55
Cancer 1,053,491 Disease Disease Constipation 15,810 1,685 0.01 -0.94 0.11 0.58
Cancer 1,053,491 Disease Target CD146 729 79 0.00 -0.94 0.11 0.55
Cancer 1,053,491 Disease Target AACT 109 12 0.00 -0.94 0.11 0.55
Cancer 1,053,491 Disease Disease Diarrhea 51,986 5,526 0.02 -0.94 0.11 0.59
Cancer 1,053,491 Disease Target Udp-Glucuronosyltransferase 2,219 250 0.01 -0.94 0.11 0.56
Cancer 1,053,491 Disease Target CD-RAP 44 5 0.00 -0.94 0.11 0.54
Cancer 1,053,491 Disease Target Vitamin D Receptor Interacting Protein 17 2 0.00 -0.94 0.12 0.54
Cancer 1,053,491 Disease Target Collagenase 3 367 45 0.00 -0.94 0.12 0.55
Cancer 1,053,491 Disease Target Glutathione S-Transferase Mu 2 8 1 0.00 -0.94 0.12 0.54
Cancer 1,053,491 Disease Target Exodus-3 8 1 0.00 -0.94 0.12 0.54
Cancer 1,053,491 Disease Target Maleylacetoacetate Isomerase 32 4 0.00 -0.94 0.12 0.55
Cancer 1,053,491 Disease Disease Gallbladder Disease 1,424 178 0.00 -0.94 0.12 0.56
Cancer 1,053,491 Disease Target Buserelin 1,249 157 0.00 -0.93 0.13 0.56
Cancer 1,053,491 Disease Target CD95 4,266 541 0.01 -0.93 0.13 0.57
Cancer 1,053,491 Disease Target Alpha-1 AntiChymotrypsin 1,460 188 0.00 -0.93 0.13 0.56
Cancer 1,053,491 Disease Disease Leukemia 162,805 18,482 0.04 -0.93 0.11 0.61
Cancer 1,053,491 Disease Target Endothelin A Receptor 722 94 0.00 -0.93 0.13 0.56
Cancer 1,053,491 Disease Drug Alendronate Sodium (Fosamax)- FDA 38 5 0.00 -0.93 0.13 0.55
Cancer 1,053,491 Disease Target Peroxisome Proliferator-Activated Receptor Delta 355 47 0.00 -0.93 0.13 0.56
Cancer 1,053,491 Disease Disease Multiple Myeloma 24,594 3,199 0.02 -0.93 0.13 0.59
Cancer 1,053,491 Disease Drug Kaempferide 60 8 0.00 -0.93 0.13 0.55
Cancer 1,053,491 Disease Target ANGPT2 105 14 0.00 -0.93 0.13 0.55
Cancer 1,053,491 Disease Drug Drupanin 22 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Target DC-CK1 22 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Target CA 50 1,293 178 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Disease Andropause 317 44 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Target Retinoic Acid Receptor Alpha 1,068 149 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Target CCL21 808 113 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Disease Leukemias 14,152 1,978 0.02 -0.93 0.14 0.59
Cancer 1,053,491 Disease Drug Abciximab (ReoPro)- FDA 7 1 0.00 -0.93 0.14 0.54
Cancer 1,053,491 Disease Drug Kabiramide C 7 1 0.00 -0.93 0.14 0.54
Cancer 1,053,491 Disease Target AMY2B 21 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Target CAMK2B 21 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Target Alpha Platelet-Derived Growth Factor Receptor 21 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Target FABP1 90 13 0.00 -0.92 0.14 0.55
Cancer 1,053,491 Disease Disease Postgastrectomy 829 120 0.00 -0.92 0.14 0.56
Cancer 1,053,491 Disease Target CLK1 62 9 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Target EPHB1 137 20 0.00 -0.92 0.15 0.55